CSOP Hang Seng HK-US TECH ETF(03442.HK) Rose 0.47% to 8.600
Newtimespace News, as of 11:28 on May 14, CSOP Hang Seng HK-US TECH ETFF (03442.HK) was quoted at HKD 8.600, up 0.47%. The ETF opened at HKD 8.735, with a high of HKD 8.790 and a low of HKD 8.560. The latest NAV per unit is HKD 8.615, with a premium rate of -0.64%. The asset size is approximately HKD 646 million.
CSOP Hang Seng HK-US TECH ETF(03442.HK) tracks the Hang Seng Stock Connect US Technology Index, which is compiled and published by Hang Seng Indexes Company Limited. The index aims to reflect the overall performance of leading U.S.-listed technology companies that are tradable through Stock Connect. The index selects 20 of the most representative technology-related companies from major U.S. indices such as the Nasdaq 100 and S&P 500, covering industries including internet software & services, semiconductors, and hardware technology & equipment. It serves as one of the key benchmarks for measuring the performance of overseas Chinese tech stocks and core U.S. technology enterprises.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- TAN CHONG INT'L (00693.HK): Expected Unrealised Investment Loss of HK$512 Million for First Half Due to Share Price Movements of Listed Investments
- SBP GROUP (01177.HK): NDA Accepted for Category 1 Innovative Drug IDH1 Inhibitor TQB3454 for Advanced Biliary Tract Cancer
- Pizu Group(09893.HK): Change of Independent Non-executive Director, Appointment of Wei Lai
- DUFU LIQUOR GP (00986.HK): Li Jingfu Appointed CEO of Subsidiary to Lead Research on AI Digital Human and Internet Marketing Business
- SSY GROUP (02005.HK): Propylthiouracil Tablets and Calcium Gluconate and Sodium Chloride Injection Obtain Drug Registration Approvals, Deemed to Have Passed Consistency Evaluation